speb/financial-data huggingface dataset:
CRI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -25947000.00
CRI balance_sheet (annual, 2022-12-31) — Net PPE: 682157000.00
CRI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 120000000.00
CRI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 258119000.00
CRI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 41235000.00
CRI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 41235000.00
CRI income_statement (annual, 2022-12-31) — Normalized EBITDA: 453733000.00
CRI income_statement (annual, 2022-12-31) — Normalized Income: 272883839.18
CRI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 88361000.00
CRI cash_flow (annual, 2022-12-31) — Operating Gains Losses: 19862000.00
CRI income_statement (annual, 2022-12-31) — Operating Income: 388171000.00
CRI income_statement (annual, 2022-12-31) — Operating Revenue: 3212733000.00
CRI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 37692132.00
CRI balance_sheet (annual, 2022-12-31) — Other Current Assets: 17917000.00
CRI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 23303000.00
CRI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -34338000.00
CRI income_statement (annual, 2022-12-31) — Other Income Expense: -29915000.00
CRI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 328957000.00
CRI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2869000.00
CRI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 30548000.00
CRI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 34757000.00
CRI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -975000.00
CRI income_statement (annual, 2022-12-31) — Other Operating Expenses: -25820000.00
CRI balance_sheet (annual, 2022-12-31) — Other Properties: 492335000.00
CRI balance_sheet (annual, 2022-12-31) — Other Receivables: 19957000.00
CRI income_statement (annual, 2022-12-31) — Other Special Charges: 19940000.00
CRI income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 3714000.00
CRI balance_sheet (annual, 2022-12-31) — Payables: 292007000.00
CRI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 339614000.00
CRI cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 0.00
CRI balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23600000.00
CRI balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CRI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 15895000.00
CRI income_statement (annual, 2022-12-31) — Pretax Income: 316736000.00
CRI cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 4457000.00
CRI balance_sheet (annual, 2022-12-31) — Properties: 332971000.00
CRI cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 5114000.00
CRI balance_sheet (annual, 2022-12-31) — Receivables: 198587000.00
CRI balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -9259000.00
CRI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1740375000.00
CRI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 65276000.00
CRI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -620000000.00
CRI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -299667000.00
CRI balance_sheet (annual, 2022-12-31) — Retained Earnings: 830370000.00
CRI cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CRI income_statement (annual, 2022-12-31) — Selling General And Administration: 1110007000.00
CRI balance_sheet (annual, 2022-12-31) — Share Issued: 37692132.00
CRI cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 240000000.00
CRI cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -120000000.00
CRI income_statement (annual, 2022-12-31) — Special Income Charges: -28940000.00
CRI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 21879000.00
CRI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 796409000.00
CRI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 258119000.00
CRI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -6094160.82
CRI income_statement (annual, 2022-12-31) — Tax Provision: 66698000.00
CRI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CRI balance_sheet (annual, 2022-12-31) — Total Assets: 2439715000.00
CRI balance_sheet (annual, 2022-12-31) — Total Capitalization: 1413033000.00
CRI balance_sheet (annual, 2022-12-31) — Total Debt: 1180797000.00
CRI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 796409000.00
CRI income_statement (annual, 2022-12-31) — Total Expenses: 2824562000.00
CRI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1643306000.00
CRI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1250995000.00
CRI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1114357000.00
CRI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 379171000.00
CRI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 27929000.00
CRI income_statement (annual, 2022-12-31) — Total Unusual Items: -28940000.00
CRI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -28940000.00
CRI cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 2475000.00
CRI balance_sheet (annual, 2022-12-31) — Working Capital: 659771000.00
CRI income_statement (annual, 2023-12-31) — +Operating Expense: 1072530000.00
CRI income_statement (annual, 2023-12-31) — +Total Revenue: 2945594000.00
CRI balance_sheet (annual, 2023-12-31) — Accounts Payable: 242149000.00
CRI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 167352000.00
CRI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -615907000.00
CRI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 0.00
CRI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -4754000.00
CRI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 3732000.00
CRI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 3732000.00
CRI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CRI income_statement (annual, 2023-12-31) — Basic Average Shares: 36589922.00
CRI income_statement (annual, 2023-12-31) — Basic EPS: 6.24
CRI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 211748000.00
CRI cash_flow (annual, 2023-12-31) — Capital Expenditure: -59860000.00
CRI cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -59860000.00
CRI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 584179000.00
CRI balance_sheet (annual, 2023-12-31) — Capital Stock: 366000.00
CRI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 351213000.00
CRI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 351213000.00
CRI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -112005000.00
CRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -332645000.00
CRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -59860000.00
CRI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 529132000.00
CRI cash_flow (annual, 2023-12-31) — Change In Account Payable: -16946000.00
CRI cash_flow (annual, 2023-12-31) — Change In Inventory: 222920000.00
CRI cash_flow (annual, 2023-12-31) — Change In Payable: -16946000.00
CRI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -16946000.00
CRI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 4317000.00
CRI cash_flow (annual, 2023-12-31) — Change In Receivables: 15453000.00
CRI cash_flow (annual, 2023-12-31) — Change In Working Capital: 225744000.00
CRI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 15453000.00
CRI cash_flow (annual, 2023-12-31) — Changes In Cash: 136627000.00
CRI balance_sheet (annual, 2023-12-31) — Common Stock: 366000.00
CRI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -112005000.00
CRI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 845250000.00
CRI cash_flow (annual, 2023-12-31) — Common Stock Payments: -100034000.00
CRI balance_sheet (annual, 2023-12-31) — Construction In Progress: 9557000.00
CRI income_statement (annual, 2023-12-31) — Cost Of Revenue: 1549659000.00
CRI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 12458000.00
CRI balance_sheet (annual, 2023-12-31) — Current Assets: 1101243000.00
CRI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 135369000.00
CRI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 135369000.00
CRI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 25162000.00
CRI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 25162000.00
CRI balance_sheet (annual, 2023-12-31) — Current Liabilities: 511862000.00
CRI cash_flow (annual, 2023-12-31) — Deferred Income Tax: -600000.00
CRI cash_flow (annual, 2023-12-31) — Deferred Tax: -600000.00
CRI cash_flow (annual, 2023-12-31) — Depreciation: 60407000.00
CRI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 64139000.00
CRI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 64139000.00
CRI income_statement (annual, 2023-12-31) — Diluted Average Shares: 36593266.00
CRI income_statement (annual, 2023-12-31) — Diluted EPS: 6.24
CRI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 228215000.00
CRI income_statement (annual, 2023-12-31) — EBIT: 336215000.00
CRI income_statement (annual, 2023-12-31) — EBITDA: 400354000.00
CRI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2838000.00
CRI cash_flow (annual, 2023-12-31) — End Cash Position: 351213000.00
CRI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -332645000.00
CRI balance_sheet (annual, 2023-12-31) — Finished Goods: 537125000.00
CRI cash_flow (annual, 2023-12-31) — Free Cash Flow: 469272000.00
CRI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 3078000.00
CRI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -23915000.00
CRI balance_sheet (annual, 2023-12-31) — Goodwill: 210537000.00
CRI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 535961000.00
CRI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 172106000.00
CRI balance_sheet (annual, 2023-12-31) — Gross PPE: 1327425000.00
CRI income_statement (annual, 2023-12-31) — Gross Profit: 1395935000.00
CRI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CRI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 76500000.00
CRI balance_sheet (annual, 2023-12-31) — Income Tax Payable: 12697000.00
CRI income_statement (annual, 2023-12-31) — Interest Expense: 33973000.00
CRI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 33973000.00
CRI income_statement (annual, 2023-12-31) — Interest Income: 4776000.00
CRI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4776000.00
CRI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 32300000.00
CRI balance_sheet (annual, 2023-12-31) — Inventory: 537125000.00
CRI balance_sheet (annual, 2023-12-31) — Invested Capital: 1342604000.00
CRI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -59860000.00
CRI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 70000000.00
CRI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 448810000.00
CRI balance_sheet (annual, 2023-12-31) — Long Term Debt: 497354000.00
CRI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 946164000.00
CRI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CRI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
CRI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 432432000.00
CRI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -100034000.00
CRI balance_sheet (annual, 2023-12-31) — Net Debt: 146141000.00
CRI cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -207000.00
CRI income_statement (annual, 2023-12-31) — Net Income: 232500000.00
CRI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 228215000.00
CRI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 232500000.00
CRI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 232500000.00
CRI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 232500000.00
CRI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 232500000.00
CRI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 232500000.00
CRI income_statement (annual, 2023-12-31) — Net Interest Income: -29197000.00
CRI cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CRI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -120000000.00
CRI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
CRI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -29197000.00
CRI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -5024000.00
CRI balance_sheet (annual, 2023-12-31) — Net PPE: 711518000.00
CRI cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -120000000.00
CRI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 309289000.00
CRI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 41470000.00
CRI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 41470000.00
CRI income_statement (annual, 2023-12-31) — Normalized EBITDA: 400354000.00
CRI income_statement (annual, 2023-12-31) — Normalized Income: 232500000.00
CRI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 529132000.00
CRI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 2871000.00
CRI income_statement (annual, 2023-12-31) — Operating Income: 323405000.00
CRI income_statement (annual, 2023-12-31) — Operating Revenue: 2945594000.00
CRI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 36551221.00
CRI balance_sheet (annual, 2023-12-31) — Other Current Assets: 15064000.00
CRI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 32373000.00
CRI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -23915000.00
CRI income_statement (annual, 2023-12-31) — Other Income Expense: 8034000.00
CRI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 325424000.00
CRI cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2780000.00
CRI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 29891000.00
CRI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 33867000.00
CRI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 8034000.00
CRI income_statement (annual, 2023-12-31) — Other Operating Expenses: -21410000.00
CRI balance_sheet (annual, 2023-12-31) — Other Properties: 528407000.00
CRI balance_sheet (annual, 2023-12-31) — Other Receivables: 24785000.00
CRI income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 4285000.00
CRI balance_sheet (annual, 2023-12-31) — Payables: 267755000.00
CRI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 280213000.00
CRI cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 0.00
CRI balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 38745000.00
CRI balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CRI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 14067000.00
CRI income_statement (annual, 2023-12-31) — Pretax Income: 302242000.00
CRI cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 4418000.00
CRI balance_sheet (annual, 2023-12-31) — Properties: 357029000.00
CRI cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -9968000.00
CRI balance_sheet (annual, 2023-12-31) — Receivables: 183774000.00
CRI balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -8363000.00
CRI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1549659000.00
CRI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 64139000.00
CRI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -190000000.00
CRI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -100034000.00
CRI balance_sheet (annual, 2023-12-31) — Retained Earnings: 868799000.00
CRI cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CRI income_statement (annual, 2023-12-31) — Selling General And Administration: 1093940000.00
CRI balance_sheet (annual, 2023-12-31) — Share Issued: 36551221.00
CRI cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 70000000.00
CRI cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -190000000.00
CRI income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CRI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19463000.00
CRI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 845250000.00
CRI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 309289000.00
CRI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRI income_statement (annual, 2023-12-31) — Tax Provision: 69742000.00
CRI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
CRI balance_sheet (annual, 2023-12-31) — Total Assets: 2378613000.00
CRI balance_sheet (annual, 2023-12-31) — Total Capitalization: 1342604000.00
CRI balance_sheet (annual, 2023-12-31) — Total Debt: 1081533000.00
CRI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 845250000.00
CRI income_statement (annual, 2023-12-31) — Total Expenses: 2622189000.00
CRI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1533363000.00
CRI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1277370000.00
CRI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1021501000.00
CRI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 323405000.00
CRI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 25606000.00
CRI income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CRI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CRI cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -2237000.00
CRI balance_sheet (annual, 2023-12-31) — Working Capital: 589381000.00
CRI cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 148000.00
CRI cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
CRI cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
CRI income_statement (annual, 2024-12-31) — +Operating Expense: 1080438000.00
CRI income_statement (annual, 2024-12-31) — +Total Revenue: 2844102000.00
CRI balance_sheet (annual, 2024-12-31) — Accounts Payable: 248200000.00
CRI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 177662000.00
CRI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -602670000.00
CRI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 3856000.00
CRI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10053000.00
CRI balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10053000.00
CRI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 3693000.00
CRI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 3693000.00
CRI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 30000000.00
CRI cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 30630000.00
CRI income_statement (annual, 2024-12-31) — Basic Average Shares: 35524378.00
CRI income_statement (annual, 2024-12-31) — Basic EPS: 5.12
CRI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 351213000.00
CRI cash_flow (annual, 2024-12-31) — Capital Expenditure: -56165000.00
CRI cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -56165000.00
CRI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 632067000.00
CRI balance_sheet (annual, 2024-12-31) — Capital Stock: 360000.00
CRI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 412926000.00
CRI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 412926000.00
CRI cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -116178000.00
CRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -174816000.00
CRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -56165000.00
CRI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 298787000.00
CRI cash_flow (annual, 2024-12-31) — Change In Account Payable: 2159000.00
CRI cash_flow (annual, 2024-12-31) — Change In Inventory: 26131000.00
CRI cash_flow (annual, 2024-12-31) — Change In Payable: 2159000.00
CRI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2159000.00
CRI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2962000.00
CRI cash_flow (annual, 2024-12-31) — Change In Receivables: -13743000.00
CRI cash_flow (annual, 2024-12-31) — Change In Working Capital: 11585000.00
CRI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -13743000.00
CRI cash_flow (annual, 2024-12-31) — Changes In Cash: 67806000.00
CRI balance_sheet (annual, 2024-12-31) — Common Stock: 360000.00
CRI cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -116178000.00
CRI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 854562000.00
CRI cash_flow (annual, 2024-12-31) — Common Stock Payments: -50526000.00
CRI cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
CRI balance_sheet (annual, 2024-12-31) — Construction In Progress: 8158000.00
CRI balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 8158000.00
CRI income_statement (annual, 2024-12-31) — Cost Of Revenue: 1478936000.00
CRI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 12345000.00
CRI balance_sheet (annual, 2024-12-31) — Current Assets: 1142672000.00
CRI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 130564000.00
CRI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 130564000.00
CRI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 25043000.00
CRI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 25043000.00
CRI balance_sheet (annual, 2024-12-31) — Current Liabilities: 508816000.00
CRI cash_flow (annual, 2024-12-31) — Deferred Income Tax: -6422000.00
CRI cash_flow (annual, 2024-12-31) — Deferred Tax: -6422000.00
CRI cash_flow (annual, 2024-12-31) — Depreciation: 54233000.00
CRI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 57926000.00
CRI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 57926000.00
CRI income_statement (annual, 2024-12-31) — Diluted Average Shares: 35525616.00
CRI income_statement (annual, 2024-12-31) — Diluted EPS: 5.12
CRI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 181830000.00
CRI income_statement (annual, 2024-12-31) — EBIT: 262140000.00
CRI income_statement (annual, 2024-12-31) — EBITDA: 320066000.00
CRI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -6093000.00
CRI cash_flow (annual, 2024-12-31) — End Cash Position: 412926000.00
CRI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -174816000.00
CRI balance_sheet (annual, 2024-12-31) — Finished Goods: 502332000.00
CRI cash_flow (annual, 2024-12-31) — Free Cash Flow: 242622000.00
CRI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 865000.00
CRI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -43678000.00
CRI balance_sheet (annual, 2024-12-31) — Goodwill: 206875000.00
CRI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 498426000.00
CRI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 187715000.00
CRI balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 187715000.00
CRI balance_sheet (annual, 2024-12-31) — Gross PPE: 1360759000.00
CRI income_statement (annual, 2024-12-31) — Gross Profit: 1365166000.00
CRI income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 30000000.00
CRI cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 51300000.00
CRI balance_sheet (annual, 2024-12-31) — Income Tax Payable: 13820000.00
CRI balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 13820000.00
CRI income_statement (annual, 2024-12-31) — Interest Expense: 31331000.00
CRI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 31331000.00
CRI income_statement (annual, 2024-12-31) — Interest Income: 11039000.00
CRI income_statement (annual, 2024-12-31) — Interest Income Non Operating: 11039000.00
CRI cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 29500000.00
CRI balance_sheet (annual, 2024-12-31) — Inventory: 502332000.00
CRI balance_sheet (annual, 2024-12-31) — Invested Capital: 1352689000.00
CRI cash_flow (annual, 2024-12-31) — Investing Cash Flow: -56165000.00
CRI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CRI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 501503000.00
CRI balance_sheet (annual, 2024-12-31) — Long Term Debt: 498127000.00
CRI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 999630000.00
CRI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CRI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
CRI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 400295000.00
CRI balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 400295000.00
CRI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -50526000.00
CRI cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CRI balance_sheet (annual, 2024-12-31) — Net Debt: 85201000.00
CRI cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 380000.00
CRI income_statement (annual, 2024-12-31) — Net Income: 185509000.00
CRI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 181830000.00
CRI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 185509000.00
CRI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 185509000.00
CRI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 185509000.00
CRI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 185509000.00
CRI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 185509000.00
CRI income_statement (annual, 2024-12-31) — Net Interest Income: -20292000.00
CRI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CRI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CRI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -20292000.00
CRI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -8479000.00
CRI balance_sheet (annual, 2024-12-31) — Net PPE: 758089000.00
CRI cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CRI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 356136000.00
CRI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 38210000.00
CRI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 38210000.00
CRI income_statement (annual, 2024-12-31) — Normalized EBITDA: 350066000.00
CRI income_statement (annual, 2024-12-31) — Normalized Income: 209621014.70
CRI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 298787000.00
CRI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2194000.00
CRI income_statement (annual, 2024-12-31) — Operating Income: 284728000.00
CRI income_statement (annual, 2024-12-31) — Operating Revenue: 2844102000.00
CRI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 36041995.00
CRI balance_sheet (annual, 2024-12-31) — Other Current Assets: 13229000.00
CRI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 40808000.00
CRI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -43678000.00
CRI income_statement (annual, 2024-12-31) — Other Income Expense: -33627000.00
CRI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 291551000.00
CRI cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1630000.00
CRI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 33980000.00
CRI balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 31949000.00
CRI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -3627000.00
CRI income_statement (annual, 2024-12-31) — Other Operating Expenses: -19251000.00
CRI balance_sheet (annual, 2024-12-31) — Other Properties: 577133000.00
CRI balance_sheet (annual, 2024-12-31) — Other Receivables: 17172000.00
CRI balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CRI balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
CRI income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 3679000.00
CRI balance_sheet (annual, 2024-12-31) — Payables: 276475000.00
CRI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 288820000.00
CRI cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 949000.00
CRI cash_flow (quarterly, 2024-12-31) — Pension And Employee Benefit Expense: 0.00
CRI balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23581000.00
CRI balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRI balance_sheet (annual, 2024-12-31) — Prepaid Assets: 19351000.00
CRI balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 19351000.00
CRI income_statement (annual, 2024-12-31) — Pretax Income: 230809000.00
CRI cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 367000.00
CRI cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CRI balance_sheet (annual, 2024-12-31) — Properties: 375173000.00
CRI balance_sheet (quarterly, 2024-12-31) — Properties: 375173000.00
CRI cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 738000.00
CRI balance_sheet (annual, 2024-12-31) — Receivables: 194834000.00
CRI balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -4390000.00
CRI balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -4390000.00
CRI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1478936000.00
CRI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 57926000.00
CRI cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
CRI cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -50526000.00
CRI cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CRI balance_sheet (annual, 2024-12-31) — Retained Earnings: 894024000.00
CRI income_statement (annual, 2024-12-31) — Selling General And Administration: 1099689000.00
CRI balance_sheet (annual, 2024-12-31) — Share Issued: 36041995.00
CRI cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
CRI cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
CRI cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
CRI income_statement (annual, 2024-12-31) — Special Income Charges: -30000000.00
CRI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 17841000.00
CRI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 854562000.00
CRI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 356136000.00
CRI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5887985.30
CRI income_statement (annual, 2024-12-31) — Tax Provision: 45300000.00
CRI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.20
CRI balance_sheet (annual, 2024-12-31) — Total Assets: 2433167000.00
CRI balance_sheet (annual, 2024-12-31) — Total Capitalization: 1352689000.00
CRI balance_sheet (annual, 2024-12-31) — Total Debt: 1130194000.00
CRI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 854562000.00
CRI income_statement (annual, 2024-12-31) — Total Expenses: 2559374000.00
CRI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1578605000.00
CRI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1290495000.00
CRI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1069789000.00
CRI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 254728000.00
CRI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 28275000.00
CRI income_statement (annual, 2024-12-31) — Total Unusual Items: -30000000.00
CRI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -30000000.00
CRI cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -2214000.00
CRI balance_sheet (annual, 2024-12-31) — Working Capital: 633856000.00
CRI income_statement (quarterly, 2025-03-31) — +Operating Expense: 264988000.00
CRI income_statement (quarterly, 2025-03-31) — +Total Revenue: 629827000.00
CRI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 199056000.00
CRI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 196109000.00
CRI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -612079000.00
CRI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 9385000.00
CRI cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 914000.00
CRI cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 914000.00
CRI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 35312090.00
CRI income_statement (quarterly, 2025-03-31) — Basic EPS: 0.43
CRI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 412926000.00
CRI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -10346000.00
CRI cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -10346000.00
CRI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 624184000.00
CRI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 362000.00
CRI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 320794000.00
CRI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 320794000.00
CRI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -28999000.00
CRI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -33591000.00
CRI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -10346000.00
CRI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -48644000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -93968000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Inventory: 27122000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Payable: -93968000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -93968000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -19035000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -8603000.00
CRI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -94484000.00
CRI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -8603000.00
CRI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -92581000.00
CRI balance_sheet (quarterly, 2025-03-31) — Common Stock: 362000.00
CRI cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -28999000.00
CRI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 847245000.00
CRI cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CRI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 338737000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4766000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Assets: 1049007000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 125556000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 125556000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 24275000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 24275000.00
CRI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 409346000.00
CRI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 6572000.00
CRI cash_flow (quarterly, 2025-03-31) — Deferred Tax: 6572000.00
CRI cash_flow (quarterly, 2025-03-31) — Depreciation: 12340000.00
CRI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 13254000.00
CRI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 13254000.00
CRI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 35314013.00
CRI income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.43
CRI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 15254000.00
CRI income_statement (quarterly, 2025-03-31) — EBIT: 29168000.00
CRI income_statement (quarterly, 2025-03-31) — EBITDA: 42422000.00
CRI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 449000.00
CRI cash_flow (quarterly, 2025-03-31) — End Cash Position: 320794000.00
CRI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -33591000.00
CRI balance_sheet (quarterly, 2025-03-31) — Finished Goods: 474124000.00
CRI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -58990000.00
CRI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -43066000.00
CRI balance_sheet (quarterly, 2025-03-31) — Goodwill: 207125000.00
CRI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 498633000.00
CRI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1360182000.00
CRI income_statement (quarterly, 2025-03-31) — Gross Profit: 291090000.00
CRI balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 9261000.00
CRI income_statement (quarterly, 2025-03-31) — Interest Expense: 7819000.00
CRI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 7819000.00
CRI income_statement (quarterly, 2025-03-31) — Interest Income: 3142000.00
CRI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3142000.00
CRI balance_sheet (quarterly, 2025-03-31) — Inventory: 474124000.00
CRI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1345573000.00
CRI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -10346000.00
CRI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 498628000.00
CRI balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 498328000.00
CRI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 996956000.00
CRI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CRI balance_sheet (quarterly, 2025-03-31) — Net Debt: 177534000.00
CRI cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -295000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income: 15539000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 15254000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 15539000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 15539000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 15539000.00
CRI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 15539000.00
CRI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 15539000.00
CRI income_statement (quarterly, 2025-03-31) — Net Interest Income: -4677000.00
CRI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4677000.00
CRI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -4592000.00
CRI balance_sheet (quarterly, 2025-03-31) — Net PPE: 748103000.00
CRI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 348612000.00
CRI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 45300000.00
CRI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 45300000.00
CRI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 42422000.00
CRI income_statement (quarterly, 2025-03-31) — Normalized Income: 15539000.00
CRI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -48644000.00
CRI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -295000.00
CRI income_statement (quarterly, 2025-03-31) — Operating Income: 26102000.00
CRI income_statement (quarterly, 2025-03-31) — Operating Revenue: 629827000.00
CRI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 36237114.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 50216000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 25184000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -43066000.00
CRI income_statement (quarterly, 2025-03-31) — Other Income Expense: -76000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 291508000.00
CRI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 415000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 36057000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 32953000.00
CRI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -76000.00
CRI income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -5332000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Properties: 1360182000.00
CRI balance_sheet (quarterly, 2025-03-31) — Other Receivables: 16071000.00
CRI income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 285000.00
CRI balance_sheet (quarterly, 2025-03-31) — Payables: 216486000.00
CRI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 221252000.00
CRI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13079000.00
CRI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRI income_statement (quarterly, 2025-03-31) — Pretax Income: 21349000.00
CRI cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CRI cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 931000.00
CRI balance_sheet (quarterly, 2025-03-31) — Receivables: 203873000.00
CRI balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -8307000.00
CRI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 338737000.00
CRI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 13254000.00
CRI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CRI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 880564000.00
CRI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 270320000.00
CRI balance_sheet (quarterly, 2025-03-31) — Share Issued: 36237114.00
CRI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 9753000.00
CRI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 847245000.00
CRI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 348612000.00
CRI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRI income_statement (quarterly, 2025-03-31) — Tax Provision: 5810000.00
CRI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
CRI balance_sheet (quarterly, 2025-03-31) — Total Assets: 2331800000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1345573000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Debt: 1122512000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 847245000.00
CRI income_statement (quarterly, 2025-03-31) — Total Expenses: 603725000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1484555000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1282793000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1075209000.00
CRI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 26102000.00
CRI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 17430000.00
CRI cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -329000.00
CRI balance_sheet (quarterly, 2025-03-31) — Working Capital: 639661000.00
CRI income_statement (quarterly, 2025-06-30) — +Operating Expense: 277716000.00
CRI income_statement (quarterly, 2025-06-30) — +Total Revenue: 585313000.00
CRI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 306399000.00
CRI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 138164000.00
CRI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -598575000.00
CRI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 14460000.00
CRI cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 932000.00
CRI cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 932000.00
CRI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 35409988.00
CRI income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
CRI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 320794000.00
CRI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -16200000.00
CRI cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -16200000.00
CRI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 625806000.00
CRI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 365000.00
CRI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 338183000.00
CRI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 338183000.00
CRI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -9116000.00
CRI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -9226000.00
CRI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -16200000.00
CRI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 40306000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 111916000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Inventory: -141136000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Payable: 111916000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 111916000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -11183000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Receivables: 62671000.00
CRI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 22268000.00
CRI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 62671000.00
CRI cash_flow (quarterly, 2025-06-30) — Changes In Cash: 14880000.00
CRI balance_sheet (quarterly, 2025-06-30) — Common Stock: 365000.00
CRI cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -9116000.00
CRI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 853902000.00
CRI cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CRI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 303553000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 12333000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Assets: 1158221000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 124002000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 124002000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 24998000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 24998000.00
CRI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 525671000.00
CRI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -3023000.00